Azerbaijan, Baku, July 1 / Trend T.Jafarov /
On Saturday, Iran will start producing new modern cancer drugs, the deputy head of the Organization for Food and Drugs of the Ministry of Health of Iran Shamsali Rezazade said, Fars news website reported.
Rezazade noted that the drug Docetaxel, used in the treatment of various forms of cancer, is still imported from abroad, will soon be produced by Iran.
According to him, Iran will also produce Faktor VII as well as the drugs used in the treatment of multiple sclerosis, so that there will no longer be a necessity to import this type of drugs.
According to official statistics, 63,000 cases of cancer are revealed in Iran annually; 46,000 patients die.
However, according to the Iranian media, the real number of cancer patients is 90,000-95,000, with over 50,000-55,000 fatalities. Alongside, there are 50,000 patients with multiple sclerosis in Iran.
The U.S. and the EU sanctions, covering the financial, trade, energy and transport sectors of Iran, have led to the economic downturn. These sanctions, along with a reduction in the value of the national currency, have resulted in problems with importing drugs into the country. Thus, according to the Iranian media, nearly 90 kinds of drugs used in the treatment of certain infectious diseases, cancer, diabetes and other serious diseases are hard to find in the country.